|
469 PSNI
remains to be convinced about GB merger The Pharmaceutical
Society of Northern Ireland remains to be convinced that a merger with
the Royal Pharmaceutical Society will ensure the most effective provision
of future regulation, Raymond Blaney, director of the PSNI, told its
members at its annual general meeting last week
PJ 2006;277:469
Full Text
469 “Promoting
profession” likely to be removed from Osteopaths Act References
to promoting the profession are likely to be removed from the Osteopaths
Act 1993 in response to the Foster review, which calls for a separation
of the regulatory and professional leadership functions of four health
regulators, including the Royal Pharmaceutical Society
PJ 2006;277:469
Full Text
469 First cervical cancer
vaccine launched in UK by Sanofi Pasteur MSD Gardasil, the first vaccine
for cervical cancer, genital warts and other diseases caused by human papillomavirus
(HPV), was launched in the UK this week
PJ 2006;277:469
Full Text
470 Coles
resigns as BAPW chairman; Brownlee elected It is only full-line wholesalers
that are able safely to sort and deliver over two billion individual items each
year with astonishingly short lead times, rapidity and punctuality of supply,
said Ian Browlee, the British Association of Pharmaceutical Wholesalers'; new
chairman, at a BAPW reception at the Palace of Westminster, London, this week
PJ 2006;277:470
Full Text
470 NPA meets Pfizer to
discuss distribution Representatives of the National Pharmacy Association
met executives of Pfizer last week to discuss the manufacturer's proposed distribution
arrangements
PJ 2006;277:470
Full Text
470 Pharmacy risks marginalisation
if contract fails, AAH warns If pharmacy fails to deliver the services
outlined in the new pharmacy contract other professionals will take these revenue
streams, according to Steve Dunn, group managing director of AAH Pharmaceuticals
PJ 2006;277:470
Full Text
470 Anti-counterfeiting
system to be launched in Belgium An innovative product authentication
system designed to tackle pharmaceutical fraud and counterfeiting will be launched
in Belgium this week
PJ 2006;277:470
Full Text
470 FP10s for oxygen to
remain, Government reaffirms GPs can continue to order home oxygen
cylinders on FP10s until all patients have been moved over to the new oxygen
suppliers, health minister Andy Burnham said last week
PJ 2006;277:470
Full Text
471 Pharmacy
represented in pilot site for DoH project Pharmacist supplementary
prescriber Rod Tucker works as part of a community dermatology service that has
been selected by the Department of Health as one of 30 pilot sites for the Care
Closer to Home Demonstration Project, announced this week. The project aims to
identify examples of where a service has successfully moved from secondary to
primary care in six specialty areas: dermatology; urology; ear, nose and throat;
orthopaedics; gynaecology; and general surgery
PJ 2006;277:471
Full Text
471 Why is a minor ailments
scheme not an essential service, asks AIMp Why can we not have a national
NHS minor ailments scheme in England or Wales, asked Steven Williams, chairman
of the Association of Independent Multiple Pharmacies (AIMp), at its first annual
dinner in London last week
PJ 2006;277:471
Full Text
471 Competency framework
for pharmacist prescribers updated An updated version of the National
Prescribing Centre's competency framework for pharmacist prescribers has been
published and can be downloaded from the NPC website
PJ 2006;277:471
Full Text
471 New refund form for
Scotland A new form for receipt and refund of NHS prescription charges
is being introduced in Scotland. The new HCS(R) form is the Scottish equivalent
of the English FP57 form
PJ 2006;277:471
Full Text
471 Information to be
prescribed Information prescriptions, in addition to those for medicines, are being piloted in a £1.35m study launched by health minister Rosie Winterton this week
PJ 2006;277:471
Full Text
472 New
examination for registration in New Zealand A new process for UK-qualified
pharmacists who wish to practise in New Zealand has been adopted by the Pharmacy
Council of New Zealand and will be implemented from 1 December. A similar process
for pharmacists wishing to register in Australia was announced earlier this year
PJ 2006;277:472
Full Text
472 Pharmacists should
provide home services Pharmacists should seek funding to provide
services in people's homes, community centres and care homes, UniChem declares
in its response to the All-Party Pharmacy Group's inquiry into the future of
pharmacy
PJ 2006;277:472
Full Text
472 Access information
database via NPA website Twenty-four hour access to the National Pharmacy
Association's information department database is one of the key features of its
new website, which was officially launched last week
PJ 2006;277:472
Full Text
472 Men’s health
check-up service launched AAH has launched a men's health check-up
service that it hopes will be commissioned as an enhanced service under the community
pharmacy contract in England and Wales
PJ 2006;277:472
Full Text
473 Cochrane
review questions value of pioglitazone The value of pioglitazone (Actos)
in the treatment of type 2 diabetes mellitus is questioned in a new Cochrane
review
PJ 2006;277:473
Full Text
473 Pre-trial data showed
that TGN1412 was a high-risk compound Information submitted to regulators
showed that the compound used in the catastrophic Northwick Park trial in March
was a high-risk compound unlikely to be suitable for administration to healthy
people, a review claims
PJ 2006;277:473
Full Text
473 Extensively drug-resistant
TB is serious threat, says WHO Extensively drug-resistant tuberculosis
(XDR-TB), although relatively uncommon, poses a serious threat to public health,
the World Health Organization warned earlier this week
PJ 2006;277:473
Full Text
473 Tesco falls foul of
MHRA rule on multiple purchase offers A complaint about Tesco's advertising
of its medicines has been upheld by the Medicines and Healthcare products Regulatory
Agency
PJ 2006;277:473
Full Text
473 Domiciliary visits
exposed under smoking ban plans The Royal Pharmaceutical Society has
expressed disappointment over Government plans for smoke-free premises because
they fail to offer guidance relating to the homes of patients who are visited
by carers
PJ 2006;277:473
Full Text
473 EMEA should address
gender Not enough women are included in European clinical drug trials,
despite acknowledged gender differences in the effectiveness of treatments, say
researchers
PJ 2006;277:473
Full Text
474 Data
support scaling cetuximab dose to provoke rash Scaling up the dose
of the epidermal growth factor receptor (EGFR)-targeting agent cetuximab (Erbitux)
for patients with metastatic colorectal cancer who do not initially develop a
rash or develop only a grade 1 acneiform rash gives them a better chance of benefiting
from the treatment. This is according to interim results of the study, known
as EVEREST, presented at the European Society for Medical Oncology congress in
Istanbul earlier this month
PJ 2006;277:474
Full Text
474 Chlorhexidine mouthwash
as effective as ice at reducing oral mucositis from chemotherapy Chlorhexidine
mouthwash is as effective in reducing oral mucositis as sucking crushed ice during
bolus chemotherapy, according to a Danish study
PJ 2006;277:474
Full Text
474 Treatment for anthracycline
extravasation injuries launched A detoxifying agent for treating injuries
which result from anthracycline extravasation has been launched in the UK
PJ 2006;277:474
Full Text
474 Data reinforce sunitinib’s
role in imatinib-resistant GIST Sunitinib is of benefit for patients
with advanced gastrointestinal stromal tumours for whom treatment with imatinib
mesylate has failed, according to researchers
PJ 2006;277:474
Full Text
474 DoH CD guidance published Two
documents providing guidance on the management of Controlled Drugs have been
published by the Department of Health
PJ 2006;277:474
Full Text |
| R&D News
475 Ranibizumab
studies reveal drug's efficacy in AMD Treatment with a new
vascular endothelial growth factor — ranibizumab —
prevents vision loss and improves mean visual acuity in patients with
neovascular age-related macular degeneration, according to the results
from two trials published
PJ 2006;277:475
Full Text
475 Energy metabolism
pathways offer targets for new epilepsy drugs Investigations
of energy metabolism pathways may lead to the development of a new class
of epilepsy drugs, the authors of a paper published online this week
claim
PJ 2006;277:475
Full Text
475 Anti-obesity drug
does not produce meaningful weight loss An experimental weight loss
drug known as MK-0557 is unlikely to be sufficient as monotherapy to treat obesity,
the results from a recently published trial suggest
PJ 2006;277:475
Full Text
476 Antidiabetic
may lower side effects of other agents Vildagliptin, an oral dipeptidyl
peptidase-IV (DPP-IV) inhibitor in development for type 2 diabetes, has surprised
investigators by showing it can attenuate side effects of other antidiabetic
medicines when used in combination
PJ 2006;277:476
Full Text
476 Study provides evidence
of link between isotretinoin and depression The first study to demonstrate
that giving isotretinoin to mice enhances depression-related behaviours was published
PJ 2006;277:476
Full Text
476 Phase III data offer
hope to patients with opioid-induced constipation Phase III study
data have shown that the selective peripheral opioid-receptor antagonist alvimopan
can relieve the symptoms of opioid-induced constipation (OIC)
PJ 2006;277:476
Full Text |
The
Pharmaceutical Journal